 Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: CompletedAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: 10-029, NCT01111838Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: OtherProtocol IDs: 10-137, NCT01200238Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: CompletedAge: 18 and overSponsor: NCI, OtherProtocol IDs: 2010-070, NCI-2010-02328, NCT01270880Phase: Phase IIType: TreatmentStatus: CompletedAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: 10-145, NCT01273896Phase: Phase IIType: TreatmentStatus: CompletedAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: 9090-09, NCT01562015Phase: Phase IType: TreatmentStatus: ClosedAge: 18 and overSponsor: OtherProtocol IDs: IRB00049962, WCI2005-11MMRC037, NCT01485835Phase: Phase IType: BiomarkerLaboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: OtherProtocol IDs: IRB00054181, STA 9090, NCT01554969 